Champions Oncology
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Champions Oncology generated cash of -$6,137,000, which is less than the previous year. Cash used in financing activities reached the amount of -$527,000 last year. Net change in cash is therefore -$7,500,000.
Cash Flow
| 2015 | -9.63M | -114K | 13.21M |
|---|---|---|---|
| 2016 | -6.45M | -322K | 2K |
| 2017 | -2.84M | -766K | 4.31M |
| 2018 | -1.22M | -1.22M | 13K |
| 2019 | 1.86M | -834K | 1.20M |
| 2020 | 2.90M | -2.22M | 4.42M |
| 2021 | -1.68M | -3.16M | 1.19M |
| 2022 | 6.49M | -2.38M | 207K |
| 2023 | 3.95M | -2.87M | 11K |
| 2024 | -6.13M | -836K | -527K |
CSBR Cash Flow Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 10.11M | 9.00M | 4.68M | 8.34M | 3.23M | 1.00M | 3.29M | 2.58M | 9.35M | 5.89M |
Operating activities | ||||||||||
Net income | -7.27M | -5.33M | 548K | 334K | -1.97M | 128K | -1.50M | -6.88M | -10.44M | -13.14M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 1.86M | 2.24M | 1.62M | 1.18M | 825K | 606K | 360K | 168K | 156K | 214K |
Stock-based compensation expense | 1.11M | 864K | 912K | 598K | 600K | 636K | 1.00M | 2.66M | 2.59M | 3.16M |
| Deferred income tax benefit | 1.11M | 864K | 912K | 598K | 600K | 636K | 1.00M | 2.66M | 2.59M | 3.16M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -1.99M | 1.30M | -2.81M | -2.26M | -670K | -531K | -1.6M | -986K | -282K | 265K |
Inventories | 0 | 0 | 0 | -1.09M | 1.03M | 571K | -27K | 404K | -199K | -194K |
Accounts payable | 465K | 2.46M | 974K | -1.24M | 333K | 653K | 301K | -43K | 482K | 433K |
Cash generated by operating activities | -6.13M | 3.95M | 6.49M | -1.68M | 2.90M | 1.86M | -1.22M | -2.84M | -6.45M | -9.63M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -836K | -2.87M | -2.38M | -3.28M | -2.22M | -834K | -1.22M | -766K | -322K | -119K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 3K | 0 | 0 | 0 |
Cash generated by investing activities | -836K | -2.87M | -2.38M | -3.16M | -2.22M | -834K | -1.22M | -766K | -322K | -114K |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 207K | 1.36M | 4.45M | 6K | 30K | 4.34M | 44K | 11.22M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -634K | -74K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -146K | 0 | 0 | -174K | -35K | -262K | -25K | -24K | -24K | -12K |
Cash used in financing activities | -527K | 11K | 207K | 1.19M | 4.42M | 1.20M | 13K | 4.31M | 2K | 13.21M |
Net Change In Cash | -7.5M | 1.09M | 4.32M | -3.65M | 5.10M | 2.23M | -2.43M | 710K | -6.77M | 3.46M |
Cash at end of period | 2.61M | 10.10M | 9.00M | 4.68M | 8.34M | 3.23M | 856K | 3.29M | 2.58M | 9.35M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |